CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Operating Expenses [Abstract]
Research and development	$ 16,926	$ 14,240	$ 31,286	$ 24,947
General and administrative	4,218	3,401	7,889	6,587
Total operating expenses	21,144	17,641	39,175	31,534
Operating loss	(21,144)	(17,641)	(39,175)	(31,534)
Other income (expense)
Interest income	1,684	250	3,476	259
Other income (expense), net	(62)	76	(142)	134
Total other income, net	1,622	326	3,334	393
Net loss before income tax	(19,522)	(17,315)	(35,841)	(31,141)
Income tax expense				(4,420)
Net loss	$ (19,522)	$ (17,315)	$ (35,841)	$ (35,561)
Net loss per share, basic	$ (0.82)	$ (1.23)	$ (1.51)	$ (4.7)
Net loss per share, diluted	$ (0.82)	$ (1.23)	$ (1.51)	$ (4.7)
Weighted-average common shares outstanding, basic	23,790,430	14,090,455	23,776,448	7,563,283
Weighted-average common shares outstanding, diluted	23,790,430	14,090,455	23,776,448	7,563,283